Activities

AD-LEARN offers a blended, multi-format educational programme designed to meet the needs of professionals at different career stages and from different disciplines.

Mini-Courses

For residents (May 2025):

Clinical introduction to neurocognitive disorders
Primer courses on reading brain SPECT and FDG-PET studies
Peer-learning with tips, tricks, and case presentations

For technologists, radiographers, and nurses (May 2025):

Understanding the role of nuclear medicine in dementia
How to perform brain SPECT and PET studies (protocols, drug development)
Communication strategies and patient care in MCI and dementia

Online Learning Modules (October 2025- July 2026)

10 CME-accredited modules available on the ESMIT platform

Interactive and self-paced: each includes expert lectures, case studies, and knowledge checks

Covers the full spectrum: from first clinical suspicion to advanced biomarker imaging and therapeutic perspectives

Total learning time: 10–15 hours, accessible over three years

Topics include

Biomarker-based approach in neurocognitive disorders: why and how?
From cognitive complaints to suspected mild cognitive impairment or mild dementia
Biomarker-based approach in suspected typical AD syndrome
Biomarker-based approach in suspected atypical AD syndrome
Biomarker-based approach in FTLD to final diagnosis
Biomarker-based approach in suspected Lewy body disease (LBD)
Biomarker-based approach in suspected motor tauopathy (CBS, PSP spectrum)
Biomarker-based approach in cognitive impairment with no clear diagnostic hypothesis
Therapeutic options in Alzheimer’s disease
Future perspectives of functional nuclear medicine imaging in neurocognitive disorders

Capsule Videos

Short 2–3 minute video summaries highlighting key messages. Published online and through EANM Young Professionals channels, both as stand-alone educational tools and as promotion for the full course.